| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.6 | 0.4 |
| Gross profit | 0.5 | 0.1 |
| Profit before tax | -1.5 | -2.6 |
| Net income | -1.5 | -2.6 |
| EPS (diluted, $ a share) | $-0.07 | $-0.20 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +66.8% |
|---|---|
| Gross margin | 81.1% |
| Operating margin | -238.3% |
10-Q filed with the SEC, NASDAQ: AIFF. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Firefly Neuroscience, Inc.: key numbers
- Share price
- $0.8853Close, Nov 16
- Market cap
- $13.9M
- Shares outstanding
- 15.75MLatest SEC cover page
- Sector
- Technology
- Industry
- Services-Prepackaged SoftwareSIC 7372
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Firefly Neuroscience, Inc.
All →Firefly Neuroscience Leadership Change
Firefly Neuroscience terminated Paul Krzywicki as Chief Financial Officer and appointed Jessica Paz as Chief Accounting Officer, effective September 8, 2026. Ms. Paz will receive an annual base salary of $215,000 and was granted stock options for 50,000 shares vesting over four years. The company stated the CFO's departure was not due to any disagreement regarding operations, policies, or practices.